This study is a biomedical, open label, therapeutic strategy, interventional, non-randomized, multicenter study to evaluate the non compliance to antimalarials in patients with systemic lupus in the Nord Pas-de-Calais region (FRANCE). It is conducted in two visits. These visits consist in obtaining blood sample, performing a clinical examination and filling in a questionnaire (Quality Of Life, Coping...). The goal for the noncompliants patients is to guide them towards the therapeutic education with professionals (nurses and physicians).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
158
This is the group sessions aimed to convey additional information to patients about their disease. The main objective is to learn how to better anticipate any medical problems and better manage daily life with the disease.
CH Hôpital Duchenne
Boulogne-sur-Mer, France
CH Douai
Douai, France
CH Dunkerque
Dunkirk, France
CH du Dr Schaffner
Lens, France
measure of the frequency of patients with systemic lupus noncompliants to their antimalarials treatment.
Time frame: baseline, at 12 months
hydroxychloroquinémie
Monitoring of blood levels of hydroxychloroquinémie
Time frame: between 6 months at 12 months
number of non- adherent patients
Identification of the number of non- adherent patients are being enrolled in Education Protocol Patient and number of sessions followed ;
Time frame: at 12 months
quality of life scale Coping
scale Coping ( WCC-R Par COUSSON et al. (1996) ) scale MASRI, scale MMAS-8-item
Time frame: baseline, at 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHRU, Hôpital Huriez
Lille, France
Victor Provo Hospital
Roubaix, France
Valenciennes hospital
Valenciennes, France